We refer to our announcements dated 12 November 2020 and 6 July 2021 in regards to the Memorandum of Understanding (“MOU”) entered into between Bintai Healthcare Sdn Bhd [Registration No. 202001027986 (1384306-P) (“BHSB”), a 50.05% owned subsidiary of the Company, and IEC Properties Pty Ltd (“IEC”) [Registration No. 122 193 168], a wholly owned subsidiary of International Equities Corporation Ltd in Australia for the proposed sole distribution rights for IEC to supply the li-Key-SARS-CoV-2 Coronavirus Vaccine to the Australia and New Zealand markets.

The Board of Directors of BKCB wishes to announce that as of todate, the MOU on the above matter remain status quo and any further development thereon shall be announced in due course.

This announcement is dated 6 October 2021.